Otonomy Company Profile (NASDAQ:OTIC)

About Otonomy (NASDAQ:OTIC)

Otonomy logoOtonomy, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. The Company's product candidates include OTIPRIO, OTO-104 and OTO-311. OTIPRIO is a single-dose, physician-administered antibacterial, which is used for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement (TTP) surgery and is available for commercial purchase. OTO-104 is a sustained-exposure formulation of the steroid dexamethasone in development for the treatment of Meniere's disease and other inner ear conditions. OTO-311 is a sustained-exposure formulation of the N-Methyl-D-Aspartate (NMDA) receptor antagonist gacyclidine in development for the treatment of tinnitus. It also has various other product candidates, which target sensorinerual hearing loss, including age-related hearing loss, also known as presbycusis.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:OTIC
  • CUSIP: N/A
  • Web: www.otonomy.com
  • Market Cap: $373.66 million
  • Outstanding Shares: 30,256,000
Average Prices:
  • 50 Day Moving Avg: $13.30
  • 200 Day Moving Avg: $14.83
  • 52 Week Range: $11.30 - $19.38
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.27
  • P/E Growth: -0.20
Sales & Book Value:
  • Annual Revenue: $1.03 million
  • Price / Sales: 362.78
  • Book Value: $5.60 per share
  • Price / Book: 2.21
  • EBIDTA: ($108,660,000.00)
  • Return on Equity: -46.65%
  • Return on Assets: -44.40%
  • Current Ratio: 17.58%
  • Quick Ratio: 17.44%
  • Average Volume: 165,133 shs.
  • Beta: 2.91
  • Short Ratio: 12.41

Frequently Asked Questions for Otonomy (NASDAQ:OTIC)

What is Otonomy's stock symbol?

Otonomy trades on the NASDAQ under the ticker symbol "OTIC."

How were Otonomy's earnings last quarter?

Otonomy Inc (NASDAQ:OTIC) released its quarterly earnings data on Thursday, May, 4th. The company reported ($0.89) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.84) by $0.05. The company earned $0.36 million during the quarter, compared to analyst estimates of $0.50 million. View Otonomy's Earnings History.

Where is Otonomy's stock going? Where will Otonomy's stock price be in 2017?

2 analysts have issued twelve-month price targets for Otonomy's shares. Their forecasts range from $29.00 to $32.00. On average, they expect Otonomy's share price to reach $30.50 in the next twelve months. View Analyst Ratings for Otonomy.

Who are some of Otonomy's key competitors?

Who owns Otonomy stock?

Otonomy's stock is owned by a number of of retail and institutional investors. Top institutional investors include Wellington Management Group LLP (13.92%), Jennison Associates LLC (12.13%), TPG Group Holdings SBS Advisors Inc. (7.14%), Vanguard Group Inc. (3.32%), Kingdon Capital Management L.L.C. (2.56%) and Schroder Investment Management Group (2.52%). Company insiders that own Otonomy stock include Carl Lebel, Chau Quang Khuong, David Allen Weber, Orbimed Advisors Llc, Paul E Cayer and Robert Michael Savel II. View Institutional Ownership Trends for Otonomy.

Who sold Otonomy stock? Who is selling Otonomy stock?

Otonomy's stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Morgan Stanley, Advisors Asset Management Inc., Driehaus Capital Management LLC, Bank of America Corp DE, Alliancebernstein L.P., Rothschild Asset Management Inc. and TIAA CREF Investment Management LLC. View Insider Buying and Selling for Otonomy.

Who bought Otonomy stock? Who is buying Otonomy stock?

Otonomy's stock was bought by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Point72 Asset Management L.P., Schroder Investment Management Group, Kingdon Capital Management L.L.C., Mirae Asset Global Investments Co. Ltd., Dimensional Fund Advisors LP, Vanguard Group Inc. and Columbus Circle Investors. View Insider Buying and Selling for Otonomy.

How do I buy Otonomy stock?

Shares of Otonomy can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Otonomy stock cost?

One share of Otonomy stock can currently be purchased for approximately $12.35.

Analyst Ratings

Consensus Ratings for Otonomy (NASDAQ:OTIC) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $30.50 (146.96% upside)

Analysts' Ratings History for Otonomy (NASDAQ:OTIC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/2/2016Piper Jaffray CompaniesReiterated RatingBuy$32.00N/AView Rating Details
5/26/2016WallachBeth CapitalInitiated CoverageBuy$29.00N/AView Rating Details
10/9/2015Bank of America CorpUpgradeNeutral -> Buy$31.00N/AView Rating Details
8/13/2015JPMorgan Chase & Co.Initiated CoverageHold$30.00N/AView Rating Details
8/10/2015Sanford C. BernsteinUpgradeMarket Perform -> Outperform$30.00N/AView Rating Details
(Data available from 5/26/2015 forward)


Earnings History for Otonomy (NASDAQ:OTIC)
Earnings by Quarter for Otonomy (NASDAQ:OTIC)
Earnings History by Quarter for Otonomy (NASDAQ:OTIC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q1 2017($0.84)($0.89)$0.50 million$0.36 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.93)($0.88)$0.49 million$0.27 millionViewListenView Earnings Details
3/7/2016Q4($0.95)($0.87)ViewListenView Earnings Details
11/10/2015Q315($0.83)($0.57)ViewN/AView Earnings Details
8/12/2015Q116($0.67)($0.52)ViewN/AView Earnings Details
5/12/2015Q115($0.53)($0.52)ViewN/AView Earnings Details
3/18/2015Q415($0.64)($0.46)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Otonomy (NASDAQ:OTIC)
Current Year EPS Consensus Estimate: $-3.37 EPS
Next Year EPS Consensus Estimate: $-2.89 EPS


Dividend History for Otonomy (NASDAQ:OTIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Otonomy (NASDAQ:OTIC)
Insider Ownership Percentage: 17.90%
Institutional Ownership Percentage: 83.55%
Insider Trades by Quarter for Otonomy (NASDAQ:OTIC)
Institutional Ownership by Quarter for Otonomy (NASDAQ:OTIC)
Insider Trades by Quarter for Otonomy (NASDAQ:OTIC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/21/2016Carl LebelInsiderSell10,625$18.07$191,993.75View SEC Filing  
12/21/2015Carl LebelinsiderSell21,250$28.04$595,850.00View SEC Filing  
12/17/2015Paul E. CayerinsiderSell3,000$29.70$89,100.00View SEC Filing  
12/15/2015David Allen WeberCEOSell5,208$27.25$141,918.00View SEC Filing  
12/14/2015Robert Michael Savel IIinsiderSell5,000$26.00$130,000.00View SEC Filing  
11/30/2015Chau Quang KhuongDirectorSell67,106$28.93$1,941,376.58View SEC Filing  
11/24/2015Orbimed Advisors LlcDirectorSell200,800$28.56$5,734,848.00View SEC Filing  
11/19/2015Chau Quang KhuongDirectorSell138,398$28.62$3,960,950.76View SEC Filing  
11/17/2015Paul E. CayerinsiderSell3,000$28.69$86,070.00View SEC Filing  
11/16/2015David Allen WeberCEOSell5,208$28.57$148,792.56View SEC Filing  
11/13/2015David Allen WeberCEOSell10,416$30.95$322,375.20View SEC Filing  
11/11/2015David Allen WeberCEOSell5,208$24.95$129,939.60View SEC Filing  
11/11/2015Paul E. CayerCFOSell3,000$24.95$74,850.00View SEC Filing  
9/21/2015Carl LebelinsiderSell21,250$24.36$517,650.00View SEC Filing  
9/17/2015Paul E. CayerCFOSell3,000$24.95$74,850.00View SEC Filing  
9/15/2015David Allen WeberCEOSell5,216$24.95$130,139.20View SEC Filing  
9/14/2015Robert Michael Savel IIinsiderSell5,000$23.98$119,900.00View SEC Filing  
6/15/2015Robert Michael Savel IIInsiderSell25,000$23.73$593,250.00View SEC Filing  
8/19/2014A/S NovoInsiderBuy15,690$15.50$243,195.00View SEC Filing  
8/18/2014A/S NovoInsiderBuy171,875$16.00$2,750,000.00View SEC Filing  
8/18/2014Jay LichterDirectorSell50,001$16.00$800,016.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Otonomy (NASDAQ:OTIC)
Latest Headlines for Otonomy (NASDAQ:OTIC)
finance.yahoo.com logoETFs with exposure to Otonomy, Inc. : May 23, 2017
finance.yahoo.com - May 23 at 6:33 PM
americanbankingnews.com logoOtonomy Inc (OTIC) Cut to "Sell" at Zacks Investment Research
www.americanbankingnews.com - May 18 at 8:26 PM
americanbankingnews.com logoZacks Investment Research Downgrades Otonomy Inc (OTIC) to Hold
www.americanbankingnews.com - May 14 at 8:58 PM
finance.yahoo.com logoOtonomy Announces OTIPRIO® Data Presentation and Symposium at the American Society of Pediatric Otolaryngology Annual Meeting
finance.yahoo.com - May 12 at 8:26 AM
finance.yahoo.com logoETFs with exposure to Otonomy, Inc. : May 11, 2017
finance.yahoo.com - May 11 at 7:34 PM
finance.yahoo.com logoOtonomy to Present at the Bank of America Merrill Lynch Health Care Conference
finance.yahoo.com - May 10 at 7:17 PM
finance.yahoo.com logoOtonomy, Inc. :OTIC-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
finance.yahoo.com - May 10 at 11:50 AM
nasdaq.com logoNoteworthy Tuesday Option Activity: OTIC, YELP, NVDA
www.nasdaq.com - May 9 at 6:39 PM
americanbankingnews.com logoSunTrust Banks Weighs in on Otonomy Inc's FY2021 Earnings (OTIC)
www.americanbankingnews.com - May 8 at 12:28 PM
americanbankingnews.com logoOtonomy Inc (OTIC) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - May 7 at 6:26 PM
americanbankingnews.com logoOtonomy Inc (OTIC) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS
www.americanbankingnews.com - May 5 at 4:40 PM
marketbeat.com logoOtonomy reports 1Q loss
marketbeat.com - May 4 at 7:17 PM
finance.yahoo.com logoInvestor Network: Otonomy, Inc. to Host Earnings Call
finance.yahoo.com - May 4 at 7:16 PM
finance.yahoo.com logoOtonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update
finance.yahoo.com - May 4 at 7:16 PM
americanbankingnews.com logoOtonomy (OTIC) Earning Favorable Media Coverage, Report Finds
www.americanbankingnews.com - May 3 at 6:26 PM
americanbankingnews.com logoOtonomy (OTIC) Getting Positive Press Coverage, Study Shows
www.americanbankingnews.com - April 29 at 6:33 PM
finance.yahoo.com logoOtonomy, Inc. – Value Analysis (NASDAQ:OTIC) : April 28, 2017
finance.yahoo.com - April 28 at 8:09 PM
finance.yahoo.com logoOtonomy to Report First Quarter 2017 Financial Results and Provide Corporate Update
finance.yahoo.com - April 27 at 7:33 PM
finance.yahoo.com logoOtonomy, Inc. breached its 50 day moving average in a Bullish Manner : OTIC-US : April 27, 2017
finance.yahoo.com - April 27 at 10:18 AM
americanbankingnews.com logoOtonomy (OTIC) Receives News Sentiment Rating of 0.24
www.americanbankingnews.com - April 26 at 7:52 PM
americanbankingnews.com logoOtonomy (OTIC) Receiving Somewhat Favorable News Coverage, Report Finds
www.americanbankingnews.com - April 22 at 1:59 PM
americanbankingnews.com logoOtonomy (OTIC) Earning Very Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - April 18 at 10:23 AM
nasdaq.com logoCommit To Buy Otonomy At $10, Earn 10.1% Annualized Using Options
www.nasdaq.com - April 8 at 6:20 PM
americanbankingnews.com logoShort Interest in Otonomy Inc (OTIC) Grows By 8.7%
www.americanbankingnews.com - April 5 at 10:52 PM
finance.yahoo.com logoEdited Transcript of OTIC earnings conference call or presentation 2-Mar-17 9:30pm GMT
finance.yahoo.com - March 31 at 7:13 PM
247wallst.com logo5 Biotech Stocks That Could Skyrocket From Upcoming Catalysts
247wallst.com - March 21 at 11:10 AM
finance.yahoo.com logoOTONOMY, INC. Financials
finance.yahoo.com - March 8 at 3:45 PM
finance.yahoo.com logoOtonomy reports 4Q loss - Yahoo Finance
finance.yahoo.com - March 3 at 12:18 AM
us.rd.yahoo.com logoOtonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
us.rd.yahoo.com - March 2 at 7:17 PM
us.rd.yahoo.com logo4:27 pm Otonomy reports Q4, issues guidance
us.rd.yahoo.com - March 2 at 7:17 PM
biz.yahoo.com logoQ4 2016 Otonomy Inc Earnings Release - After Market Close
biz.yahoo.com - March 2 at 8:46 AM
biz.yahoo.com logoOtonomy Inc Earnings Call scheduled for 4:30 pm ET today
biz.yahoo.com - March 2 at 8:46 AM
finance.yahoo.com logoOtonomy to Present at Cowen and Company Health Care Conference
finance.yahoo.com - February 28 at 7:08 PM
globenewswire.com logoOtonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update - GlobeNewswire (press release)
globenewswire.com - February 24 at 8:10 PM
feeds.benzinga.com logoOtonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update
feeds.benzinga.com - February 24 at 8:12 AM
finance.yahoo.com logoOtonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss
finance.yahoo.com - January 19 at 11:43 PM
biz.yahoo.com logoOTONOMY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - January 13 at 11:58 PM
finance.yahoo.com logoOtonomy Provides Corporate and Product Pipeline Update
finance.yahoo.com - January 9 at 7:45 PM
finance.yahoo.com logo7:34 am Otonomy expects 2016 Non-GAAP operating expenses to be at the low end of the $100-105 mln previous guidance range; sees 2017 non-GAAP operating expenses of $85-90 mln
finance.yahoo.com - January 9 at 7:45 PM
streetinsider.com logoOtonomy (OTIC) Says Phase 3 Clinical Trial of OTIPRIO Met Primary Endpoint
www.streetinsider.com - January 5 at 11:50 PM
us.rd.yahoo.com logoOtonomy's ear infection drug succeeds in late-stage trial
us.rd.yahoo.com - January 5 at 11:50 PM
publicnow.com logoOtonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis Externa
us.rd.yahoo.com - January 5 at 11:50 PM
finance.yahoo.com logoOtonomy to Present at the J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 10:22 AM



Otonomy (OTIC) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff